Pro-Vegetarian Diets, Microbial/Metabolite Profiles and Cancer (MIVECA)

November 20, 2022 updated by: Esther Molina-Montes, Universidad de Granada

Characterizacion of Pro-VEgetarian Diets: Diet Quality and Nutrition, MIcrobial/Metabolite Profiles and Implications in CAncer (MIVECA Study)

This projects aims to characterize dietary habits and nutrition quality of pro-vegetarian diets as compared to omnivorous diets. It also aims to stablish gut microbial and metabolit profiles of this dietary pattern, in order to elucidate the role of plant-based diets in cancer prevention and treatment.

Study Overview

Detailed Description

Plant-based foods (fruits, vegetables, cereals, nuts and seeds, legumes, and vegetable oils) are the main source of fiber and other bioactive compounds in the diet. Plant-based diets are therefore assumed to prevent mortality and the ocurrence of chronic diseases including cancer. However, evidence on this issue is still scarce, and the mechanisms and drivers of their potential health benefits are also only partially known.

The main objectices of this project are:

  1. To develop and validate dietary assessment methods for the vegetarian population
  2. To assess dietary habits and consumer beliefs of vegetarians with respect to omnivores, considering different types of vegetarian diets
  3. To identify a gut microbiota signature related to plant-based diets from subgroups of subjects following a plant-based diet foods (vegans, lacto-vegetarians, …, and pro-vegetarians) and omnivorous subjects (non-plant-based diets), from stool metagenomic sequencing.
  4. To relate this signature with metabolites present in faeces (related to the presence of certain microbial species) and in urine to improve the predictive capacity of the microbial signature of vegetable diets.
  5. Validate the signature using independent study populations, and including colorectal and breast cancer survivors as another study target.

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Esther Molina Montes
  • Phone Number: 958240750
  • Email: memolina@ugr.es

Study Contact Backup

Study Locations

      • Barcelona, Spain
        • Not yet recruiting
        • Idibell Ico
        • Contact:
          • Mireia Obon Santacana
        • Sub-Investigator:
          • Mireia Obon Santacana
      • Donostia, Spain
        • Not yet recruiting
        • Biodonostia
        • Contact:
          • Pilar Amiano
        • Sub-Investigator:
          • Pilar Amiano
      • Granada, Spain
        • Recruiting
        • University of Granada
        • Contact:
          • Esther Molina Montes, Doctor
          • Phone Number: 958240750
          • Email: memolina@ugr.es
        • Principal Investigator:
          • Esther Molina-Montes
        • Sub-Investigator:
          • Maria Dolores Ruiz Lopez
        • Sub-Investigator:
          • Reyes Artacho
        • Sub-Investigator:
          • Belen Garcia-Villanova
        • Sub-Investigator:
          • Vito Verardo
        • Sub-Investigator:
          • Maria Jose Sanchez Perez
        • Sub-Investigator:
          • Miguel Rodriguez Barranco
      • Madrid, Spain
        • Not yet recruiting
        • Csic-Ictan
        • Contact:
          • Beatriz Sarria
        • Sub-Investigator:
          • Beatriz Sarria
      • Sevilla, Spain
        • Not yet recruiting
        • CSIC-IG
        • Contact:
        • Principal Investigator:
          • Noelia M Rodriguez-Martin
        • Sub-Investigator:
          • Justo J Pedroche Jimenez
        • Sub-Investigator:
          • Ana L Lemus-Conejo
        • Sub-Investigator:
          • Rocio M Toscano Sanchez
      • Tarragona, Spain
        • Not yet recruiting
        • IISPV Pere Virgili
        • Contact:
          • Raquel Cumeras
        • Sub-Investigator:
          • Raquel Cumeras

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

University students and staff, mainly. Healthy volunteers from the general population. The control group will be matched by age and sex to the vegetarian diet study groups.

Description

Inclusion Criteria:

-

Exclusion Criteria:

  • pregnancy or lactation
  • antibiotic treatment in the previous 2 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Omnivours
100 subjects (comparison group)
This is an observational study. The control group (omnivours) will be compared with all otgher groups
Vegans
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
This is an observational study. The control group (omnivours) will be compared with all otgher groups
Lacto-ovo-vegetarians
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
This is an observational study. The control group (omnivours) will be compared with all otgher groups
Pesco-vegetarians
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
This is an observational study. The control group (omnivours) will be compared with all otgher groups
Pro-vegetarians
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
This is an observational study. The control group (omnivours) will be compared with all otgher groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary habits obtention from vegetarians: the dietary intake
Time Frame: 3 months
Dietary habits will be taken by an online specific Food Frequency Questionnaire (FFQ) for Spanish population, including novel vegetarian foods to evaluate vegetarian food consumption. The data analysis will be taken at baseline outcome.
3 months
Dietary assessment validation methods: 24-hour-recalls and dietary intake biomarkers
Time Frame: 6 monts
To validated dietary assessment method, two 24-Hour-Recalls in two non-consecutive days will be used, as well as the analysis of specific vegetarian diet metabolites in urine and stool samples using Ultra performance liquid chromatography - tandem mass spectrometer (UPLC-MS/MS). The data analysis will be taken at baseline. We have estimated that 200 subjects will be sufficient to detect, with a 95% confidence and power of 90%, correlation coefficients greater than rho=0.2.
6 monts

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

September 29, 2022

First Submitted That Met QC Criteria

November 11, 2022

First Posted (Actual)

November 17, 2022

Study Record Updates

Last Update Posted (Actual)

November 25, 2022

Last Update Submitted That Met QC Criteria

November 20, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PPJIA2021-38

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on This is an observational study

3
Subscribe